GEHC geopolitical news & exposure
GEHC geopolitical news and exposure. GEHC appears in 170 Geopolitics Alpha notes. The newest is 22 Sep 2026, 16:23 UTC. Stored price-reaction rows cover 0 of those notes.
- FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
22 Sep 2026, 16:23 UTC
- This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
22 Sep 2026, 15:46 UTC
- Celldex sinks as safety concerns cloud immune drug results
22 Sep 2026, 15:42 UTC
- Notable ETF Outflow Detected - XBI, TWST, HALO, NTRA
22 Sep 2026, 15:05 UTC
- A hidden tradeoff in Trump’s drug pricing deals
22 Sep 2026, 11:00 UTC
- Cordis wins FDA approval for sirolimus-eluting balloon
22 Sep 2026, 09:56 UTC
- Novo CEO signals M&A opportunities to strengthen drug pipeline
22 Sep 2026, 09:00 UTC
- US strikes on alleged drug boats may be ‘crimes against humanity’, UN says
22 Sep 2026, 03:52 UTC
- Higher rates may not be bad for biotech stocks: find out more
21 Sep 2026, 21:06 UTC
- Patient Listening Session Summaries
21 Sep 2026, 13:57 UTC
- FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing
21 Sep 2026, 12:58 UTC
- Drugs@FDA Data Files
21 Sep 2026, 12:57 UTC
- FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development
21 Sep 2026, 12:57 UTC
- FDA Roundup: June 18, 2024
21 Sep 2026, 12:18 UTC
- US strikes on alleged drug boats could be crimes against humanity, says UN
21 Sep 2026, 12:08 UTC
- Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
21 Sep 2026, 12:06 UTC
- How J&J paved the way for Compass’ coming psychedelic drug launch
21 Sep 2026, 11:30 UTC
- Brazil pharmaceutical distributors face mounting financial pressure
21 Sep 2026, 11:20 UTC
- FDA
21 Sep 2026, 10:26 UTC
- Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
21 Sep 2026, 10:03 UTC
- Are healthcare systems really ready for GLP-1s?
21 Sep 2026, 09:00 UTC
- Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
21 Sep 2026, 08:58 UTC
- Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
21 Sep 2026, 04:20 UTC
- Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial
20 Sep 2026, 01:01 UTC
- Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices
19 Sep 2026, 21:12 UTC
- FDA Expedited Investigational New Drug (IND) Pilot Program
18 Sep 2026, 19:55 UTC
- Generic Drugs
18 Sep 2026, 19:31 UTC
- Electra amasses $350M in biotech’s latest big IPO
18 Sep 2026, 00:42 UTC
- Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2027
18 Sep 2026, 00:00 UTC
- Lisata deal propels Marea’s drug pipeline to Wall Street
17 Sep 2026, 21:39 UTC
- FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
17 Sep 2026, 18:26 UTC
- North Immunology joins biotech reverse merger boom with Aethlon deal
17 Sep 2026, 15:09 UTC
- Recor Medical ex-CEO Lara Barghout joins Medtronic
16 Sep 2026, 19:52 UTC
- TTD Expands Pharma Reach: Can New Healthcare Integrations Drive Growth
16 Sep 2026, 13:04 UTC
- FDA clears first generic radioligand drug; Sionna turns to layoffs
15 Sep 2026, 21:13 UTC
- FDA launches pilot program to speed up early US drug research
15 Sep 2026, 14:00 UTC
- FDA Launches Expedited IND Pilot, Begins Accepting Applications
15 Sep 2026, 13:53 UTC
- Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
14 Sep 2026, 20:41 UTC
- Beta Bionics’ insulin patch pump gets FDA nod
14 Sep 2026, 19:22 UTC
- Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing
14 Sep 2026, 15:46 UTC